Smiths Medical Recalls Infusion Pumps over 3 Problems

Smiths Medical recalls infusion pumps over 3 problems

Smiths has not reported any serious injuries or deaths related to the issues, but the FDA sees a risk of harm.

Class I Recall Notices: Three Infusion Pump Corrections from Smiths Medical - TechNation

The U.S. Food and Drug Administration (FDA) is aware that Smiths Medical has issued three letters to affected customers that certain CADD-Solis Ambulatory Infusion Pumps and CADD-Solis VIP Ambulatory Infusion Pumps have updated use instructions. Smiths Medical has notified affected users of corrections to the following: Infusion Pump False Occlusion Alarm: Under certain conditions, a

Infusion Pump Recalls Affect More Than 300,000 CADD-Solis Portable Devices: FDA

Federal health officials have announced three recalls for Smiths Medical CADD-Solis infusion pumps due to malfunctions that may interrupt therapy, posing a risk of serious injury or death.

Smiths Medical warns on trio of infusion pump issues

The FDA issued three notices identifying warnings sent out by ICU Medical‘s Smiths Medical unit related to infusion pump problems. Smiths Medical warned of issues with some of its CADD-Solis and CADD-Solis VIP ambulatory infusion pumps. The CADD-Solis pump offers utility in hospital or outpatient settings, delivering pain therapies. CADD-Solis VIP pumps are intended for use in a home care setting by patients and/or their caregivers with proper t…

FDA MedWatch - Class I Recall Notices: Three Infusion Pump Corrections from Smiths Medical